证券代码：688560 证券简称：明冠新材 公告编号：2025-025 明冠新材料股份有限公司 第四届监事会第二十二次会议决议公告 二、监事会会议审议情况 （一）审议通过《关于定增募集资金投资项目之"嘉明薄膜公司年产 1 亿 平米无氟背板建设项目"结项并将节余募集资金永久补充流动资金的议案》 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 明冠新材料股份有限公司（以下简称"公司"）第四届监事会第二十二次会 议于 2025 年 6 月 30 日在公司会议室以现场结合通讯表决方式召开。本次会议通 知已于 2025 年 6 月 23 日以邮件方式送达全体监事。本次会议应出席监事 3 名， 实际出席监事 3 名，会议由监事会主席李成利先生主持。本次会议的通知、召开 及审议程序符合《中华人民共和国公司法》和《明冠新材料股份有限公司章程》 （以下简称"《公司章程》"）的有关规定。 具体内容详见公司同日在上海证券交易所网站（www.sse.com.cn）披露的《明 冠新材料股份有限公司关于部分定增募集资金投资项目 ...

Core Viewpoint - The company has completed the investment project "Jiaming Film Company's annual production of 100 million square meters of fluorine-free backplane construction" and will permanently supplement its working capital with the remaining raised funds of 188.3751 million yuan [1][8][9]. Fundraising Basic Situation - The company raised a total of 1,675.38 million yuan by issuing 37,214,182 shares at a price of 45.02 yuan per share, with a net amount of 1,655.88 million yuan after deducting issuance costs [1][3]. - The funds have been fully received and verified by Tianjian Accounting Firm [1]. Project and Fund Usage Situation - The total investment for the project was 415.8 million yuan, with cumulative input of 218.2653 million yuan, resulting in a surplus of 188.3751 million yuan [6][7]. - The project has reached a usable state as of June 23, 2025 [5][6]. Reasons for Fund Surplus - The company adhered to regulations and implemented strict cost control measures during the project, leading to reduced equipment procurement costs due to price drops in the photovoltaic industry [6][7]. - Adjustments in project investment processes and designs were made based on market conditions, maximizing efficiency and minimizing costs [6][7]. Future Use of Surplus Funds - The surplus funds will be permanently used to supplement the company's working capital for daily operations, while maintaining a dedicated account until all pending payments are settled [8][9]. - The company will ensure that the use of surplus funds does not harm shareholder interests and complies with relevant regulations [8][9]. Review Procedures - The board of directors and the supervisory board approved the project completion and fund allocation, confirming compliance with legal and regulatory requirements [9][10].